Virtu Financial’s Alnylam Pharmaceuticals ALNY Stock Holding History

Virtu Financial’s Portfolio ALNY Stock Details ALNY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-2,941	Closed	-$1.17M	–	1587
2025 Q4	$1.17M	Sell	2,941 -8,715	-75%	-$3.86M	0.05%	298
2025 Q3	$5.32M	Buy	+11,656	New	+$4.75M	0.3%	52
2023 Q3	–	Sell	-1,808	Closed	-$343K	–	1252
2023 Q2	$343K	Buy	+1,808	New	+$358K	0.03%	553
2022 Q2	–	Sell	-3,862	Closed	-$631K	–	1540
2022 Q1	$631K	Sell	3,862 -4,445	-54%	-$677K	0.05%	327
2021 Q4	$1.41M	Buy	+8,307	New	+$1.54M	0.14%	135
2021 Q3	–	Sell	-3,092	Closed	-$524K	–	1457
2021 Q2	$524K	Buy	+3,092	New	+$453K	0.05%	452
2019 Q4	$1.28M	Buy	+11,147	New	+$1.11M	0.12%	177
2019 Q2	–	Sell	-3,720	Closed	-$348K	–	1430
2019 Q1	$348K	Buy	+3,720	New	+$311K	0.02%	719
2018 Q4	–	Sell	-7,884	Closed	-$690K	–	1521
2018 Q3	$690K	Buy	7,884 +2,817	+56%	+$283K	0.04%	464
2018 Q2	$499K	Sell	5,067 -4,405	-47%	-$437K	0.03%	794
2018 Q1	$1.13M	Buy	+9,472	New	+$1.22M	0.06%	318
2017 Q4	–	Sell	-2,435	Closed	-$286K	–	2327
2017 Q3	$286K	Buy	+2,435	New	+$208K	0.01%	1434
2015 Q3	–	Sell	-3,837	Closed	-$460K	–	311
2015 Q2	$460K	Buy	+3,837	New	+$459K	0.04%	213

Other funds holding ALNY

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Virtu Financial's ALNY Position: Q1 2026 in Review

Virtu Financial sold out of Alnylam Pharmaceuticals (ALNY) in Q1 2026, closing a stake of 2,941 shares — an estimated $1.17M sold.

Virtu Financial first reported a position in ALNY in Q2 2015 and held it in 13 quarters. The position peaked at $5.32M in Q3 2025. 786 funds tracked by Wall St. Rank hold ALNY as of Q1 2026.

Virtu Financial reported no remaining Alnylam Pharmaceuticals position as of Q1 2026 after selling out during the quarter.
Virtu Financial sold 2,941 Alnylam Pharmaceuticals shares in Q1 2026, an estimated $1.17M.
Virtu Financial first reported a position in Alnylam Pharmaceuticals in Q2 2015 and held it in 13 quarters.
Virtu Financial's Alnylam Pharmaceuticals position peaked at $5.32M in Q3 2025.
786 funds tracked by Wall St. Rank held Alnylam Pharmaceuticals as of Q1 2026.

Based on Virtu Financial's 13F filing for Q1 2026, filed 14 May 2026.